Studies

CellWell record HH-136886

Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study

Md Shadin; Md Shimul Bhuia; Mohammed Alfaifi; Faisal H Altemani; Abdullah H Altemani; Faisal Alsenani; Na'il Saleh; Muhammad Torequl Islam

2026

In plain language

A meta-analysis of over 30 RCTs found probiotics, synbiotics, and berberine produced modest but significant reductions in fasting glucose and HbA1c in type 2 diabetes, with weaker enzyme binding for berberine than acarbose.

Evidence
Established
Design
Meta-analysis

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-136886

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.